PS1250 PRIMARY THERAPY AND SURVIVAL OF FOLLICULAR LYMPHOMA IN THE NETHERLANDS: A POPULATION‐BASED ANALYSIS AMONG 12,008 PATIENTS DIAGNOSED FROM 1989 TO 2016

Background: Follicular lymphoma (FL) is a heterogenous malignancy, reflected, in part, by the highly variable clinical course. Major advances over the past decades in diagnosis, classification, and management—especially the introduction of rituximab—have significantly contributed to improved survival among patients with FL. At present, however, population‐based studies that comprehensively assessed the contribution of these advances on survival according to disease stage are scarce. Aims: The aim of this nationwide population‐based study was to assess trends in primary therapy and survival amo... Mehr ...